| Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity BL Lampson, SN Kasar, TR Matos, EA Morgan, L Rassenti, MS Davids, ... Blood, The Journal of the American Society of Hematology 128 (2), 195-203, 2016 | 341 | 2016 |
| The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanism MA Anderson, J Deng, JF Seymour, C Tam, SY Kim, J Fein, L Yu, ... Blood, The Journal of the American Society of Hematology 127 (25), 3215-3224, 2016 | 340 | 2016 |
| Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry … R Shouval, JA Fein, M Labopin, N Kröger, RF Duarte, P Bader, ... The Lancet Haematology 6 (11), e573-e584, 2019 | 202 | 2019 |
| The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy DA Landau, C Sun, D Rosebrock, SEM Herman, J Fein, M Sivina, ... Nature communications 8 (1), 2185, 2017 | 195 | 2017 |
| Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy R Shouval, A Alarcon Tomas, JA Fein, JR Flynn, E Markovits, S Mayer, ... Journal of clinical oncology 40 (4), 369-381, 2022 | 111 | 2022 |
| Machine learning and artificial intelligence in haematology R Shouval, JA Fein, B Savani, M Mohty, A Nagler British journal of haematology 192 (2), 239-250, 2021 | 111 | 2021 |
| Adverse cardiovascular and pulmonary events associated with chimeric antigen receptor T-cell therapy A Goldman, E Maor, D Bomze, JE Liu, J Herrmann, J Fein, RM Steingart, ... Journal of the American College of Cardiology 78 (18), 1800-1813, 2021 | 109 | 2021 |
| External validation and comparison of multiple prognostic scores in allogeneic hematopoietic stem cell transplantation R Shouval, JA Fein, A Shouval, I Danylesko, N Shem-Tov, M Zlotnik, ... Blood Advances 3 (12), 1881-1890, 2019 | 87 | 2019 |
| Risk factors and implications of oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation R Shouval, E Kouniavski, J Fein, I Danylesko, N Shem‐Tov, M Geva, ... European Journal of Haematology 103 (4), 402-409, 2019 | 59 | 2019 |
| Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma A Alarcon Tomas, JA Fein, S Fried, JR Flynn, SM Devlin, WB Fingrut, ... Leukemia 37 (1), 154-163, 2023 | 53 | 2023 |
| Patterns of salivary microbiota injury and oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation R Shouval, A Eshel, B Dubovski, AA Kuperman, I Danylesko, JA Fein, ... Blood advances 4 (13), 2912-2917, 2020 | 53 | 2020 |
| Validation of the acute leukemia‐EBMT score for prediction of mortality following allogeneic stem cell transplantation in a multi‐center GITMO cohort R Shouval, F Bonifazi, J Fein, C Boschini, E Oldani, M Labopin, ... American journal of hematology 92 (5), 429-434, 2017 | 49 | 2017 |
| The impact of individual comorbidities on non-relapse mortality following allogeneic hematopoietic stem cell transplantation JA Fein, A Shimoni, M Labopin, N Shem-Tov, R Yerushalmi, H Magen, ... Leukemia 32 (8), 1787-1794, 2018 | 47 | 2018 |
| Prognostic scoring systems in allogeneic hematopoietic stem cell transplantation: where do we stand? R Potdar, G Varadi, J Fein, M Labopin, A Nagler, R Shouval Biology of Blood and Marrow Transplantation 23 (11), 1839-1846, 2017 | 41 | 2017 |
| Interplay of immunosuppression and immunotherapy among patients with cancer and COVID-19 Z Bakouny, C Labaki, P Grover, J Awosika, S Gulati, CY Hsu, ... JAMA oncology 9 (1), 128-134, 2023 | 40 | 2023 |
| Idelalisib given front-line for the treatment of chronic lymphocytic leukemia results in frequent and severe immune-mediated toxicities BL Lampson, T Matos, HT Kim, S Kasar, EA Morgan, M Hirakawa, J Fein, ... Blood 126 (23), 497, 2015 | 39 | 2015 |
| Efficacy results of a phase 2 trial of first-line idelalisib plus ofatumumab in chronic lymphocytic leukemia BL Lampson, HT Kim, MS Davids, JS Abramson, AS Freedman, ... Blood advances 3 (7), 1167-1174, 2019 | 34 | 2019 |
| Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood … R Shouval, JA Fein, M Labopin, C Cho, A Bazarbachi, F Baron, G Bug, ... The Lancet Haematology 8 (3), e205-e215, 2021 | 32 | 2021 |
| An integrative scoring system for survival prediction following umbilical cord blood transplantation in acute leukemia R Shouval, A Ruggeri, M Labopin, M Mohty, G Sanz, G Michel, J Kuball, ... Clinical Cancer Research 23 (21), 6478-6486, 2017 | 32 | 2017 |
| Point-of-care anti-CD19 CAR T-cells for treatment of relapsed and refractory aggressive B-cell lymphoma M Kedmi, R Shouval, S Fried, D Bomze, J Fein, Z Cohen, I Danilesko, ... Transplantation and cellular therapy 28 (5), 251-257, 2022 | 27 | 2022 |
Roni ShouvalAdult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NYVerified email at mskcc.org